nodes	percent_of_prediction	percent_of_DWPC	metapath
Memantine—HTR3A—fourth ventricle—brain cancer	0.0448	0.127	CbGeAlD
Memantine—GRIN1—telencephalic ventricle—brain cancer	0.0235	0.0667	CbGeAlD
Memantine—GRIN2B—telencephalic ventricle—brain cancer	0.0224	0.0636	CbGeAlD
Memantine—HTR3A—cranial nerve—brain cancer	0.016	0.0454	CbGeAlD
Memantine—GRIN1—ganglion—brain cancer	0.0146	0.0415	CbGeAlD
Memantine—GRIN2B—ganglion—brain cancer	0.0139	0.0396	CbGeAlD
Memantine—GRIN2A—ganglion—brain cancer	0.0122	0.0346	CbGeAlD
Memantine—GRIN1—hindbrain—brain cancer	0.0111	0.0315	CbGeAlD
Memantine—GRIN2B—hindbrain—brain cancer	0.0106	0.03	CbGeAlD
Memantine—GRIN2A—hindbrain—brain cancer	0.00924	0.0263	CbGeAlD
Memantine—HTR3A—ganglion—brain cancer	0.00808	0.023	CbGeAlD
Memantine—DRD2—telencephalic ventricle—brain cancer	0.00794	0.0226	CbGeAlD
Memantine—GRIN1—brainstem—brain cancer	0.00635	0.018	CbGeAlD
Memantine—GRIN2B—brainstem—brain cancer	0.00606	0.0172	CbGeAlD
Memantine—GRIN3A—telencephalon—brain cancer	0.00595	0.0169	CbGeAlD
Memantine—GRIN1—telencephalon—brain cancer	0.00564	0.016	CbGeAlD
Memantine—GRIN2B—telencephalon—brain cancer	0.00538	0.0153	CbGeAlD
Memantine—GRIN2A—brainstem—brain cancer	0.0053	0.0151	CbGeAlD
Memantine—DRD2—ganglion—brain cancer	0.00494	0.014	CbGeAlD
Memantine—GRIN2A—telencephalon—brain cancer	0.0047	0.0134	CbGeAlD
Memantine—GRIN1—midbrain—brain cancer	0.00405	0.0115	CbGeAlD
Memantine—GRIN1—spinal cord—brain cancer	0.00395	0.0112	CbGeAlD
Memantine—GRIN2B—spinal cord—brain cancer	0.00377	0.0107	CbGeAlD
Memantine—DRD2—hindbrain—brain cancer	0.00375	0.0107	CbGeAlD
Memantine—GRIN3A—head—brain cancer	0.0037	0.0105	CbGeAlD
Memantine—GRIN2A—medulla oblongata—brain cancer	0.00369	0.0105	CbGeAlD
Memantine—GRIN1—endocrine gland—brain cancer	0.00356	0.0101	CbGeAlD
Memantine—HTR3A—brainstem—brain cancer	0.00351	0.00998	CbGeAlD
Memantine—GRIN1—head—brain cancer	0.00351	0.00997	CbGeAlD
Memantine—CYP2A6—CYP2E1 reactions—CYP2C9—brain cancer	0.00349	0.0613	CbGpPWpGaD
Memantine—GRIN2B—endocrine gland—brain cancer	0.00339	0.00964	CbGeAlD
Memantine—GRIN3A—central nervous system—brain cancer	0.00338	0.0096	CbGeAlD
Memantine—GRIN2A—midbrain—brain cancer	0.00338	0.00959	CbGeAlD
Memantine—GRIN2B—head—brain cancer	0.00335	0.00952	CbGeAlD
Memantine—GRIN2A—spinal cord—brain cancer	0.00329	0.00936	CbGeAlD
Memantine—GRIN1—central nervous system—brain cancer	0.0032	0.0091	CbGeAlD
Memantine—GRIN1—cerebellum—brain cancer	0.00313	0.0089	CbGeAlD
Memantine—HTR3A—telencephalon—brain cancer	0.00312	0.00886	CbGeAlD
Memantine—GRIN2B—central nervous system—brain cancer	0.00306	0.00869	CbGeAlD
Memantine—GRIN2B—cerebellum—brain cancer	0.00299	0.00849	CbGeAlD
Memantine—GRIN2A—endocrine gland—brain cancer	0.00297	0.00842	CbGeAlD
Memantine—GRIN2A—head—brain cancer	0.00293	0.00832	CbGeAlD
Memantine—CYP2B6—CYP2E1 reactions—CYP2C9—brain cancer	0.00282	0.0495	CbGpPWpGaD
Memantine—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00275	0.0482	CbGpPWpGaD
Memantine—GRIN3A—brain—brain cancer	0.00268	0.00762	CbGeAlD
Memantine—GRIN2A—central nervous system—brain cancer	0.00267	0.00759	CbGeAlD
Memantine—GRIN2A—cerebellum—brain cancer	0.00261	0.00742	CbGeAlD
Memantine—GRIN1—brain—brain cancer	0.00254	0.00723	CbGeAlD
Memantine—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.0025	0.0439	CbGpPWpGaD
Memantine—GRIN2B—brain—brain cancer	0.00243	0.0069	CbGeAlD
Memantine—CYP2A6—Xenobiotics—CYP2C9—brain cancer	0.00217	0.038	CbGpPWpGaD
Memantine—DRD2—brainstem—brain cancer	0.00215	0.0061	CbGeAlD
Memantine—CYP2C19—CYP2E1 reactions—CYP2C9—brain cancer	0.00213	0.0374	CbGpPWpGaD
Memantine—GRIN2A—brain—brain cancer	0.00212	0.00603	CbGeAlD
Memantine—CYP2A6—Tamoxifen metabolism—CYP2C9—brain cancer	0.00208	0.0366	CbGpPWpGaD
Memantine—HTR3A—head—brain cancer	0.00194	0.00551	CbGeAlD
Memantine—DRD2—telencephalon—brain cancer	0.00191	0.00542	CbGeAlD
Memantine—HTR3A—central nervous system—brain cancer	0.00177	0.00503	CbGeAlD
Memantine—CYP2B6—Xenobiotics—CYP2C9—brain cancer	0.00175	0.0307	CbGpPWpGaD
Memantine—CYP2A6—cerebellum—brain cancer	0.0017	0.00483	CbGeAlD
Memantine—DRD2—pituitary gland—brain cancer	0.00155	0.00441	CbGeAlD
Memantine—CYP2A6—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.00149	0.0261	CbGpPWpGaD
Memantine—HTR3A—brain—brain cancer	0.00141	0.004	CbGeAlD
Memantine—CYP2A6—brain—brain cancer	0.00138	0.00393	CbGeAlD
Memantine—DRD2—midbrain—brain cancer	0.00137	0.00389	CbGeAlD
Memantine—CYP2C19—Xenobiotics—CYP2C9—brain cancer	0.00132	0.0232	CbGpPWpGaD
Memantine—CYP2B6—gonad—brain cancer	0.00129	0.00366	CbGeAlD
Memantine—CYP2C19—Tamoxifen metabolism—CYP2C9—brain cancer	0.00127	0.0223	CbGpPWpGaD
Memantine—CYP2C19—endocrine gland—brain cancer	0.00124	0.00353	CbGeAlD
Memantine—DRD2—endocrine gland—brain cancer	0.0012	0.00342	CbGeAlD
Memantine—CYP2B6—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.0012	0.0211	CbGpPWpGaD
Memantine—DRD2—head—brain cancer	0.00119	0.00337	CbGeAlD
Memantine—HTR3A—SIDS Susceptibility Pathways—HES5—brain cancer	0.00115	0.0201	CbGpPWpGaD
Memantine—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.00114	0.0201	CbGpPWpGaD
Memantine—DRD2—central nervous system—brain cancer	0.00108	0.00308	CbGeAlD
Memantine—DRD2—cerebellum—brain cancer	0.00106	0.00301	CbGeAlD
Memantine—GRIN1—BDNF signaling pathway—NTRK3—brain cancer	0.00105	0.0184	CbGpPWpGaD
Memantine—GRIN2B—BDNF signaling pathway—NTRK3—brain cancer	0.00102	0.018	CbGpPWpGaD
Memantine—CYP2B6—endocrine gland—brain cancer	0.000973	0.00276	CbGeAlD
Memantine—CYP2B6—head—brain cancer	0.00096	0.00273	CbGeAlD
Memantine—GRIN1—SIDS Susceptibility Pathways—HES5—brain cancer	0.000954	0.0167	CbGpPWpGaD
Memantine—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000907	0.0159	CbGpPWpGaD
Memantine—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.0009	0.0158	CbGpPWpGaD
Memantine—CYP2A6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000888	0.0156	CbGpPWpGaD
Memantine—CYP2B6—central nervous system—brain cancer	0.000876	0.00249	CbGeAlD
Memantine—DRD2—brain—brain cancer	0.000861	0.00244	CbGeAlD
Memantine—GRIN1—Spinal Cord Injury—GFAP—brain cancer	0.000802	0.0141	CbGpPWpGaD
Memantine—Haemorrhage—Carmustine—brain cancer	0.000765	0.00129	CcSEcCtD
Memantine—Ill-defined disorder—Hydroxyurea—brain cancer	0.000764	0.00129	CcSEcCtD
Memantine—Anaemia—Hydroxyurea—brain cancer	0.000761	0.00129	CcSEcCtD
Memantine—Hallucination—Carmustine—brain cancer	0.000761	0.00129	CcSEcCtD
Memantine—Hypoaesthesia—Carmustine—brain cancer	0.000761	0.00129	CcSEcCtD
Memantine—Decreased appetite—Procarbazine—brain cancer	0.000755	0.00128	CcSEcCtD
Memantine—Alanine aminotransferase increased—Etoposide—brain cancer	0.000754	0.00128	CcSEcCtD
Memantine—Oedema peripheral—Carmustine—brain cancer	0.000754	0.00127	CcSEcCtD
Memantine—Connective tissue disorder—Carmustine—brain cancer	0.000752	0.00127	CcSEcCtD
Memantine—Fatigue—Procarbazine—brain cancer	0.000749	0.00127	CcSEcCtD
Memantine—Haemoglobin—Temozolomide—brain cancer	0.000743	0.00126	CcSEcCtD
Memantine—Malaise—Hydroxyurea—brain cancer	0.000743	0.00126	CcSEcCtD
Memantine—Constipation—Procarbazine—brain cancer	0.000743	0.00126	CcSEcCtD
Memantine—Pain—Procarbazine—brain cancer	0.000743	0.00126	CcSEcCtD
Memantine—Hepatitis—Temozolomide—brain cancer	0.000739	0.00125	CcSEcCtD
Memantine—Haemorrhage—Temozolomide—brain cancer	0.000739	0.00125	CcSEcCtD
Memantine—Dysphagia—Etoposide—brain cancer	0.000739	0.00125	CcSEcCtD
Memantine—Leukopenia—Hydroxyurea—brain cancer	0.000737	0.00125	CcSEcCtD
Memantine—Visual impairment—Carmustine—brain cancer	0.000737	0.00125	CcSEcCtD
Memantine—Hallucination—Temozolomide—brain cancer	0.000735	0.00124	CcSEcCtD
Memantine—Hypoaesthesia—Temozolomide—brain cancer	0.000735	0.00124	CcSEcCtD
Memantine—Pharyngitis—Temozolomide—brain cancer	0.000734	0.00124	CcSEcCtD
Memantine—Urinary tract disorder—Temozolomide—brain cancer	0.00073	0.00124	CcSEcCtD
Memantine—CYP2A6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000729	0.0128	CbGpPWpGaD
Memantine—Oedema peripheral—Temozolomide—brain cancer	0.000728	0.00123	CcSEcCtD
Memantine—Bronchospasm—Etoposide—brain cancer	0.000727	0.00123	CcSEcCtD
Memantine—Connective tissue disorder—Temozolomide—brain cancer	0.000726	0.00123	CcSEcCtD
Memantine—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000726	0.0127	CbGpPWpGaD
Memantine—Urethral disorder—Temozolomide—brain cancer	0.000725	0.00123	CcSEcCtD
Memantine—Sweating increased—Etoposide—brain cancer	0.00072	0.00122	CcSEcCtD
Memantine—CYP2B6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000716	0.0126	CbGpPWpGaD
Memantine—Feeling abnormal—Procarbazine—brain cancer	0.000716	0.00121	CcSEcCtD
Memantine—Eye disorder—Carmustine—brain cancer	0.000715	0.00121	CcSEcCtD
Memantine—Convulsion—Hydroxyurea—brain cancer	0.000714	0.00121	CcSEcCtD
Memantine—Visual impairment—Temozolomide—brain cancer	0.000712	0.00121	CcSEcCtD
Memantine—Gastrointestinal pain—Procarbazine—brain cancer	0.00071	0.0012	CcSEcCtD
Memantine—Flushing—Carmustine—brain cancer	0.00071	0.0012	CcSEcCtD
Memantine—Pancytopenia—Etoposide—brain cancer	0.000702	0.00119	CcSEcCtD
Memantine—Erythema multiforme—Temozolomide—brain cancer	0.000699	0.00118	CcSEcCtD
Memantine—CYP2B6—brain—brain cancer	0.000696	0.00198	CbGeAlD
Memantine—Discomfort—Hydroxyurea—brain cancer	0.000693	0.00117	CcSEcCtD
Memantine—Neutropenia—Etoposide—brain cancer	0.000691	0.00117	CcSEcCtD
Memantine—Eye disorder—Temozolomide—brain cancer	0.000691	0.00117	CcSEcCtD
Memantine—Urticaria—Procarbazine—brain cancer	0.00069	0.00117	CcSEcCtD
Memantine—Tinnitus—Temozolomide—brain cancer	0.000689	0.00117	CcSEcCtD
Memantine—Abdominal pain—Procarbazine—brain cancer	0.000687	0.00116	CcSEcCtD
Memantine—Body temperature increased—Procarbazine—brain cancer	0.000687	0.00116	CcSEcCtD
Memantine—Flushing—Temozolomide—brain cancer	0.000686	0.00116	CcSEcCtD
Memantine—Cardiac disorder—Temozolomide—brain cancer	0.000686	0.00116	CcSEcCtD
Memantine—Arrhythmia—Carmustine—brain cancer	0.000683	0.00116	CcSEcCtD
Memantine—Alopecia—Carmustine—brain cancer	0.000676	0.00114	CcSEcCtD
Memantine—Oedema—Hydroxyurea—brain cancer	0.000672	0.00114	CcSEcCtD
Memantine—Angiopathy—Temozolomide—brain cancer	0.000671	0.00113	CcSEcCtD
Memantine—Mental disorder—Carmustine—brain cancer	0.00067	0.00113	CcSEcCtD
Memantine—Infection—Hydroxyurea—brain cancer	0.000668	0.00113	CcSEcCtD
Memantine—Immune system disorder—Temozolomide—brain cancer	0.000668	0.00113	CcSEcCtD
Memantine—Mediastinal disorder—Temozolomide—brain cancer	0.000666	0.00113	CcSEcCtD
Memantine—Malnutrition—Carmustine—brain cancer	0.000666	0.00113	CcSEcCtD
Memantine—Chills—Temozolomide—brain cancer	0.000663	0.00112	CcSEcCtD
Memantine—Pneumonia—Etoposide—brain cancer	0.000663	0.00112	CcSEcCtD
Memantine—Nervous system disorder—Hydroxyurea—brain cancer	0.000659	0.00112	CcSEcCtD
Memantine—Infestation NOS—Etoposide—brain cancer	0.000659	0.00111	CcSEcCtD
Memantine—Infestation—Etoposide—brain cancer	0.000659	0.00111	CcSEcCtD
Memantine—Thrombocytopenia—Hydroxyurea—brain cancer	0.000658	0.00111	CcSEcCtD
Memantine—Stevens-Johnson syndrome—Etoposide—brain cancer	0.000653	0.00111	CcSEcCtD
Memantine—Alopecia—Temozolomide—brain cancer	0.000653	0.00111	CcSEcCtD
Memantine—Skin disorder—Hydroxyurea—brain cancer	0.000653	0.0011	CcSEcCtD
Memantine—Acute coronary syndrome—Etoposide—brain cancer	0.00065	0.0011	CcSEcCtD
Memantine—Renal failure—Etoposide—brain cancer	0.000648	0.0011	CcSEcCtD
Memantine—Mental disorder—Temozolomide—brain cancer	0.000648	0.0011	CcSEcCtD
Memantine—Myocardial infarction—Etoposide—brain cancer	0.000646	0.00109	CcSEcCtD
Memantine—Neuropathy peripheral—Etoposide—brain cancer	0.000646	0.00109	CcSEcCtD
Memantine—Back pain—Carmustine—brain cancer	0.000644	0.00109	CcSEcCtD
Memantine—Malnutrition—Temozolomide—brain cancer	0.000643	0.00109	CcSEcCtD
Memantine—Anorexia—Hydroxyurea—brain cancer	0.000641	0.00108	CcSEcCtD
Memantine—Hypersensitivity—Procarbazine—brain cancer	0.00064	0.00108	CcSEcCtD
Memantine—CYP2C19—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000635	0.0111	CbGpPWpGaD
Memantine—Dysgeusia—Temozolomide—brain cancer	0.00063	0.00107	CcSEcCtD
Memantine—Vision blurred—Carmustine—brain cancer	0.000628	0.00106	CcSEcCtD
Memantine—Tremor—Carmustine—brain cancer	0.000624	0.00106	CcSEcCtD
Memantine—Asthenia—Procarbazine—brain cancer	0.000623	0.00105	CcSEcCtD
Memantine—Hepatobiliary disease—Etoposide—brain cancer	0.000623	0.00105	CcSEcCtD
Memantine—Back pain—Temozolomide—brain cancer	0.000622	0.00105	CcSEcCtD
Memantine—Anaemia—Carmustine—brain cancer	0.000615	0.00104	CcSEcCtD
Memantine—Agranulocytosis—Etoposide—brain cancer	0.000615	0.00104	CcSEcCtD
Memantine—Pruritus—Procarbazine—brain cancer	0.000615	0.00104	CcSEcCtD
Memantine—Agitation—Carmustine—brain cancer	0.000612	0.00104	CcSEcCtD
Memantine—Vision blurred—Temozolomide—brain cancer	0.000606	0.00103	CcSEcCtD
Memantine—Tremor—Temozolomide—brain cancer	0.000603	0.00102	CcSEcCtD
Memantine—Dyspnoea—Hydroxyurea—brain cancer	0.000599	0.00101	CcSEcCtD
Memantine—Somnolence—Hydroxyurea—brain cancer	0.000598	0.00101	CcSEcCtD
Memantine—Ill-defined disorder—Temozolomide—brain cancer	0.000597	0.00101	CcSEcCtD
Memantine—Leukopenia—Carmustine—brain cancer	0.000596	0.00101	CcSEcCtD
Memantine—Anaemia—Temozolomide—brain cancer	0.000595	0.00101	CcSEcCtD
Memantine—Diarrhoea—Procarbazine—brain cancer	0.000594	0.00101	CcSEcCtD
Memantine—Dyspepsia—Hydroxyurea—brain cancer	0.000592	0.001	CcSEcCtD
Memantine—Agitation—Temozolomide—brain cancer	0.000591	0.001	CcSEcCtD
Memantine—Hypoaesthesia—Etoposide—brain cancer	0.000589	0.000996	CcSEcCtD
Memantine—CYP2B6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000588	0.0103	CbGpPWpGaD
Memantine—Decreased appetite—Hydroxyurea—brain cancer	0.000584	0.000989	CcSEcCtD
Memantine—Urinary tract disorder—Etoposide—brain cancer	0.000584	0.000988	CcSEcCtD
Memantine—GRIN2B—ErbB4 signaling events—ERBB2—brain cancer	0.000582	0.0102	CbGpPWpGaD
Memantine—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.00058	0.000982	CcSEcCtD
Memantine—Malaise—Temozolomide—brain cancer	0.00058	0.000982	CcSEcCtD
Memantine—Urethral disorder—Etoposide—brain cancer	0.00058	0.000981	CcSEcCtD
Memantine—Fatigue—Hydroxyurea—brain cancer	0.00058	0.000981	CcSEcCtD
Memantine—Vertigo—Temozolomide—brain cancer	0.000578	0.000978	CcSEcCtD
Memantine—Convulsion—Carmustine—brain cancer	0.000577	0.000976	CcSEcCtD
Memantine—Leukopenia—Temozolomide—brain cancer	0.000576	0.000975	CcSEcCtD
Memantine—Hypertension—Carmustine—brain cancer	0.000575	0.000973	CcSEcCtD
Memantine—Constipation—Hydroxyurea—brain cancer	0.000575	0.000973	CcSEcCtD
Memantine—Pain—Hydroxyurea—brain cancer	0.000575	0.000973	CcSEcCtD
Memantine—Dizziness—Procarbazine—brain cancer	0.000574	0.000972	CcSEcCtD
Memantine—HTR3A—Ion channel transport—TRPC6—brain cancer	0.00057	0.01	CbGpPWpGaD
Memantine—Palpitations—Temozolomide—brain cancer	0.000569	0.000962	CcSEcCtD
Memantine—Chest pain—Carmustine—brain cancer	0.000567	0.000959	CcSEcCtD
Memantine—Myalgia—Carmustine—brain cancer	0.000567	0.000959	CcSEcCtD
Memantine—Anxiety—Carmustine—brain cancer	0.000565	0.000956	CcSEcCtD
Memantine—Cough—Temozolomide—brain cancer	0.000562	0.00095	CcSEcCtD
Memantine—Erythema multiforme—Etoposide—brain cancer	0.000559	0.000946	CcSEcCtD
Memantine—Convulsion—Temozolomide—brain cancer	0.000558	0.000943	CcSEcCtD
Memantine—Hypertension—Temozolomide—brain cancer	0.000556	0.00094	CcSEcCtD
Memantine—Feeling abnormal—Hydroxyurea—brain cancer	0.000554	0.000937	CcSEcCtD
Memantine—Eye disorder—Etoposide—brain cancer	0.000553	0.000935	CcSEcCtD
Memantine—Vomiting—Procarbazine—brain cancer	0.000552	0.000934	CcSEcCtD
Memantine—Flushing—Etoposide—brain cancer	0.000549	0.000929	CcSEcCtD
Memantine—Cardiac disorder—Etoposide—brain cancer	0.000549	0.000929	CcSEcCtD
Memantine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000548	0.00962	CbGpPWpGaD
Memantine—Confusional state—Carmustine—brain cancer	0.000548	0.000927	CcSEcCtD
Memantine—Arthralgia—Temozolomide—brain cancer	0.000548	0.000927	CcSEcCtD
Memantine—Myalgia—Temozolomide—brain cancer	0.000548	0.000927	CcSEcCtD
Memantine—Rash—Procarbazine—brain cancer	0.000548	0.000927	CcSEcCtD
Memantine—Dermatitis—Procarbazine—brain cancer	0.000547	0.000926	CcSEcCtD
Memantine—Anxiety—Temozolomide—brain cancer	0.000546	0.000924	CcSEcCtD
Memantine—Headache—Procarbazine—brain cancer	0.000544	0.000921	CcSEcCtD
Memantine—Oedema—Carmustine—brain cancer	0.000543	0.00092	CcSEcCtD
Memantine—Discomfort—Temozolomide—brain cancer	0.000541	0.000916	CcSEcCtD
Memantine—CYP2C19—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000541	0.0095	CbGpPWpGaD
Memantine—Infection—Carmustine—brain cancer	0.00054	0.000914	CcSEcCtD
Memantine—Angiopathy—Etoposide—brain cancer	0.000537	0.000908	CcSEcCtD
Memantine—Dry mouth—Temozolomide—brain cancer	0.000536	0.000907	CcSEcCtD
Memantine—Immune system disorder—Etoposide—brain cancer	0.000534	0.000904	CcSEcCtD
Memantine—Mediastinal disorder—Etoposide—brain cancer	0.000533	0.000902	CcSEcCtD
Memantine—Thrombocytopenia—Carmustine—brain cancer	0.000532	0.0009	CcSEcCtD
Memantine—Body temperature increased—Hydroxyurea—brain cancer	0.000531	0.000899	CcSEcCtD
Memantine—Chills—Etoposide—brain cancer	0.000531	0.000898	CcSEcCtD
Memantine—Tachycardia—Carmustine—brain cancer	0.00053	0.000897	CcSEcCtD
Memantine—Confusional state—Temozolomide—brain cancer	0.00053	0.000896	CcSEcCtD
Memantine—Oedema—Temozolomide—brain cancer	0.000525	0.000889	CcSEcCtD
Memantine—Alopecia—Etoposide—brain cancer	0.000523	0.000884	CcSEcCtD
Memantine—Infection—Temozolomide—brain cancer	0.000522	0.000883	CcSEcCtD
Memantine—Anorexia—Carmustine—brain cancer	0.000518	0.000876	CcSEcCtD
Memantine—Nausea—Procarbazine—brain cancer	0.000516	0.000873	CcSEcCtD
Memantine—Nervous system disorder—Temozolomide—brain cancer	0.000515	0.000871	CcSEcCtD
Memantine—Thrombocytopenia—Temozolomide—brain cancer	0.000514	0.00087	CcSEcCtD
Memantine—Skin disorder—Temozolomide—brain cancer	0.00051	0.000863	CcSEcCtD
Memantine—Hypotension—Carmustine—brain cancer	0.000508	0.000859	CcSEcCtD
Memantine—Hyperhidrosis—Temozolomide—brain cancer	0.000508	0.000859	CcSEcCtD
Memantine—Dysgeusia—Etoposide—brain cancer	0.000504	0.000853	CcSEcCtD
Memantine—Anorexia—Temozolomide—brain cancer	0.000501	0.000847	CcSEcCtD
Memantine—Back pain—Etoposide—brain cancer	0.000498	0.000843	CcSEcCtD
Memantine—Hypersensitivity—Hydroxyurea—brain cancer	0.000495	0.000838	CcSEcCtD
Memantine—Musculoskeletal discomfort—Carmustine—brain cancer	0.000495	0.000838	CcSEcCtD
Memantine—Insomnia—Carmustine—brain cancer	0.000492	0.000832	CcSEcCtD
Memantine—Paraesthesia—Carmustine—brain cancer	0.000488	0.000826	CcSEcCtD
Memantine—HTR3A—SIDS Susceptibility Pathways—ESR2—brain cancer	0.000488	0.00856	CbGpPWpGaD
Memantine—Dyspnoea—Carmustine—brain cancer	0.000484	0.00082	CcSEcCtD
Memantine—Somnolence—Carmustine—brain cancer	0.000483	0.000817	CcSEcCtD
Memantine—Asthenia—Hydroxyurea—brain cancer	0.000482	0.000816	CcSEcCtD
Memantine—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000478	0.00081	CcSEcCtD
Memantine—Ill-defined disorder—Etoposide—brain cancer	0.000478	0.000808	CcSEcCtD
Memantine—Anaemia—Etoposide—brain cancer	0.000476	0.000805	CcSEcCtD
Memantine—Insomnia—Temozolomide—brain cancer	0.000475	0.000804	CcSEcCtD
Memantine—Decreased appetite—Carmustine—brain cancer	0.000472	0.000799	CcSEcCtD
Memantine—Paraesthesia—Temozolomide—brain cancer	0.000472	0.000798	CcSEcCtD
Memantine—Gastrointestinal disorder—Carmustine—brain cancer	0.000469	0.000794	CcSEcCtD
Memantine—Dyspnoea—Temozolomide—brain cancer	0.000468	0.000792	CcSEcCtD
Memantine—Somnolence—Temozolomide—brain cancer	0.000467	0.00079	CcSEcCtD
Memantine—Pain—Carmustine—brain cancer	0.000465	0.000786	CcSEcCtD
Memantine—Constipation—Carmustine—brain cancer	0.000465	0.000786	CcSEcCtD
Memantine—Malaise—Etoposide—brain cancer	0.000464	0.000786	CcSEcCtD
Memantine—Vertigo—Etoposide—brain cancer	0.000463	0.000783	CcSEcCtD
Memantine—Dyspepsia—Temozolomide—brain cancer	0.000462	0.000782	CcSEcCtD
Memantine—Leukopenia—Etoposide—brain cancer	0.000461	0.00078	CcSEcCtD
Memantine—Diarrhoea—Hydroxyurea—brain cancer	0.00046	0.000778	CcSEcCtD
Memantine—Decreased appetite—Temozolomide—brain cancer	0.000457	0.000772	CcSEcCtD
Memantine—Gastrointestinal disorder—Temozolomide—brain cancer	0.000453	0.000767	CcSEcCtD
Memantine—Fatigue—Temozolomide—brain cancer	0.000453	0.000766	CcSEcCtD
Memantine—Loss of consciousness—Etoposide—brain cancer	0.000453	0.000766	CcSEcCtD
Memantine—Cough—Etoposide—brain cancer	0.000449	0.00076	CcSEcCtD
Memantine—Constipation—Temozolomide—brain cancer	0.000449	0.00076	CcSEcCtD
Memantine—Pain—Temozolomide—brain cancer	0.000449	0.00076	CcSEcCtD
Memantine—Feeling abnormal—Carmustine—brain cancer	0.000448	0.000758	CcSEcCtD
Memantine—Convulsion—Etoposide—brain cancer	0.000446	0.000755	CcSEcCtD
Memantine—CYP2C19—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000445	0.0078	CbGpPWpGaD
Memantine—Hypertension—Etoposide—brain cancer	0.000445	0.000752	CcSEcCtD
Memantine—Dizziness—Hydroxyurea—brain cancer	0.000445	0.000752	CcSEcCtD
Memantine—Gastrointestinal pain—Carmustine—brain cancer	0.000444	0.000752	CcSEcCtD
Memantine—Chest pain—Etoposide—brain cancer	0.000438	0.000742	CcSEcCtD
Memantine—Discomfort—Etoposide—brain cancer	0.000433	0.000733	CcSEcCtD
Memantine—Feeling abnormal—Temozolomide—brain cancer	0.000433	0.000732	CcSEcCtD
Memantine—HTR3A—Transmembrane transport of small molecules—S100A10—brain cancer	0.00043	0.00754	CbGpPWpGaD
Memantine—Body temperature increased—Carmustine—brain cancer	0.00043	0.000727	CcSEcCtD
Memantine—Abdominal pain—Carmustine—brain cancer	0.00043	0.000727	CcSEcCtD
Memantine—Gastrointestinal pain—Temozolomide—brain cancer	0.000429	0.000727	CcSEcCtD
Memantine—Vomiting—Hydroxyurea—brain cancer	0.000427	0.000723	CcSEcCtD
Memantine—Rash—Hydroxyurea—brain cancer	0.000424	0.000717	CcSEcCtD
Memantine—Confusional state—Etoposide—brain cancer	0.000424	0.000717	CcSEcCtD
Memantine—Dermatitis—Hydroxyurea—brain cancer	0.000423	0.000717	CcSEcCtD
Memantine—Headache—Hydroxyurea—brain cancer	0.000421	0.000713	CcSEcCtD
Memantine—Infection—Etoposide—brain cancer	0.000417	0.000706	CcSEcCtD
Memantine—Urticaria—Temozolomide—brain cancer	0.000417	0.000706	CcSEcCtD
Memantine—Abdominal pain—Temozolomide—brain cancer	0.000415	0.000702	CcSEcCtD
Memantine—Body temperature increased—Temozolomide—brain cancer	0.000415	0.000702	CcSEcCtD
Memantine—Thrombocytopenia—Etoposide—brain cancer	0.000411	0.000696	CcSEcCtD
Memantine—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—brain cancer	0.000411	0.00721	CbGpPWpGaD
Memantine—Tachycardia—Etoposide—brain cancer	0.00041	0.000694	CcSEcCtD
Memantine—Skin disorder—Etoposide—brain cancer	0.000408	0.000691	CcSEcCtD
Memantine—Hyperhidrosis—Etoposide—brain cancer	0.000406	0.000687	CcSEcCtD
Memantine—GRIN1—SIDS Susceptibility Pathways—ESR2—brain cancer	0.000406	0.00712	CbGpPWpGaD
Memantine—Anorexia—Etoposide—brain cancer	0.000401	0.000678	CcSEcCtD
Memantine—Hypersensitivity—Carmustine—brain cancer	0.0004	0.000677	CcSEcCtD
Memantine—Nausea—Hydroxyurea—brain cancer	0.000399	0.000676	CcSEcCtD
Memantine—Hypotension—Etoposide—brain cancer	0.000393	0.000664	CcSEcCtD
Memantine—Asthenia—Carmustine—brain cancer	0.00039	0.00066	CcSEcCtD
Memantine—CYP2A6—Biological oxidations—CYP2C9—brain cancer	0.000387	0.0068	CbGpPWpGaD
Memantine—Hypersensitivity—Temozolomide—brain cancer	0.000387	0.000655	CcSEcCtD
Memantine—HTR3A—SIDS Susceptibility Pathways—HES1—brain cancer	0.000379	0.00665	CbGpPWpGaD
Memantine—Paraesthesia—Etoposide—brain cancer	0.000377	0.000638	CcSEcCtD
Memantine—Asthenia—Temozolomide—brain cancer	0.000377	0.000638	CcSEcCtD
Memantine—Dyspnoea—Etoposide—brain cancer	0.000375	0.000634	CcSEcCtD
Memantine—Somnolence—Etoposide—brain cancer	0.000374	0.000632	CcSEcCtD
Memantine—Diarrhoea—Carmustine—brain cancer	0.000372	0.000629	CcSEcCtD
Memantine—Pruritus—Temozolomide—brain cancer	0.000372	0.000629	CcSEcCtD
Memantine—DRD2—Circadian rythm related genes—NTRK3—brain cancer	0.000369	0.00647	CbGpPWpGaD
Memantine—Decreased appetite—Etoposide—brain cancer	0.000365	0.000618	CcSEcCtD
Memantine—Gastrointestinal disorder—Etoposide—brain cancer	0.000363	0.000614	CcSEcCtD
Memantine—Fatigue—Etoposide—brain cancer	0.000362	0.000613	CcSEcCtD
Memantine—Dizziness—Carmustine—brain cancer	0.000359	0.000608	CcSEcCtD
Memantine—Constipation—Etoposide—brain cancer	0.000359	0.000608	CcSEcCtD
Memantine—Pain—Etoposide—brain cancer	0.000359	0.000608	CcSEcCtD
Memantine—Diarrhoea—Temozolomide—brain cancer	0.000359	0.000608	CcSEcCtD
Memantine—Dizziness—Temozolomide—brain cancer	0.000347	0.000588	CcSEcCtD
Memantine—Feeling abnormal—Etoposide—brain cancer	0.000346	0.000586	CcSEcCtD
Memantine—Vomiting—Carmustine—brain cancer	0.000346	0.000585	CcSEcCtD
Memantine—Gastrointestinal pain—Etoposide—brain cancer	0.000344	0.000581	CcSEcCtD
Memantine—Rash—Carmustine—brain cancer	0.000343	0.00058	CcSEcCtD
Memantine—Dermatitis—Carmustine—brain cancer	0.000342	0.000579	CcSEcCtD
Memantine—Headache—Carmustine—brain cancer	0.00034	0.000576	CcSEcCtD
Memantine—Vomiting—Temozolomide—brain cancer	0.000334	0.000565	CcSEcCtD
Memantine—Urticaria—Etoposide—brain cancer	0.000334	0.000565	CcSEcCtD
Memantine—Abdominal pain—Etoposide—brain cancer	0.000332	0.000562	CcSEcCtD
Memantine—Body temperature increased—Etoposide—brain cancer	0.000332	0.000562	CcSEcCtD
Memantine—Rash—Temozolomide—brain cancer	0.000331	0.00056	CcSEcCtD
Memantine—Dermatitis—Temozolomide—brain cancer	0.000331	0.00056	CcSEcCtD
Memantine—Headache—Temozolomide—brain cancer	0.000329	0.000557	CcSEcCtD
Memantine—Nausea—Carmustine—brain cancer	0.000323	0.000546	CcSEcCtD
Memantine—GRIN1—SIDS Susceptibility Pathways—HES1—brain cancer	0.000315	0.00553	CbGpPWpGaD
Memantine—CYP2B6—Biological oxidations—CYP2C9—brain cancer	0.000313	0.00548	CbGpPWpGaD
Memantine—Nausea—Temozolomide—brain cancer	0.000312	0.000528	CcSEcCtD
Memantine—GRIN1—BDNF signaling pathway—SPP1—brain cancer	0.000311	0.00545	CbGpPWpGaD
Memantine—Hypersensitivity—Etoposide—brain cancer	0.00031	0.000524	CcSEcCtD
Memantine—GRIN1—Spinal Cord Injury—CDK4—brain cancer	0.000309	0.00542	CbGpPWpGaD
Memantine—CYP2B6—Metapathway biotransformation—CYP2C9—brain cancer	0.000308	0.00541	CbGpPWpGaD
Memantine—GRIN2B—BDNF signaling pathway—SPP1—brain cancer	0.000303	0.00531	CbGpPWpGaD
Memantine—Asthenia—Etoposide—brain cancer	0.000302	0.00051	CcSEcCtD
Memantine—Pruritus—Etoposide—brain cancer	0.000297	0.000503	CcSEcCtD
Memantine—Diarrhoea—Etoposide—brain cancer	0.000288	0.000487	CcSEcCtD
Memantine—GRIN1—BDNF signaling pathway—IRS2—brain cancer	0.000281	0.00493	CbGpPWpGaD
Memantine—Dizziness—Etoposide—brain cancer	0.000278	0.00047	CcSEcCtD
Memantine—GRIN2B—BDNF signaling pathway—IRS2—brain cancer	0.000274	0.00481	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—TRPC6—brain cancer	0.000273	0.00478	CbGpPWpGaD
Memantine—Vomiting—Etoposide—brain cancer	0.000267	0.000452	CcSEcCtD
Memantine—GRIN2B—Axon guidance—TRPC6—brain cancer	0.000266	0.00466	CbGpPWpGaD
Memantine—Rash—Etoposide—brain cancer	0.000265	0.000448	CcSEcCtD
Memantine—Dermatitis—Etoposide—brain cancer	0.000265	0.000448	CcSEcCtD
Memantine—Headache—Etoposide—brain cancer	0.000263	0.000445	CcSEcCtD
Memantine—Nausea—Etoposide—brain cancer	0.00025	0.000422	CcSEcCtD
Memantine—GRIN1—BDNF signaling pathway—APC—brain cancer	0.000248	0.00435	CbGpPWpGaD
Memantine—GRIN2B—BDNF signaling pathway—APC—brain cancer	0.000242	0.00424	CbGpPWpGaD
Memantine—CYP2C19—Biological oxidations—CYP2C9—brain cancer	0.000236	0.00414	CbGpPWpGaD
Memantine—CYP2C19—Metapathway biotransformation—CYP2C9—brain cancer	0.000233	0.00409	CbGpPWpGaD
Memantine—GRIN1—EPH-Ephrin signaling—VEGFA—brain cancer	0.000209	0.00366	CbGpPWpGaD
Memantine—GRIN2A—Alzheimers Disease—TP53—brain cancer	0.000208	0.00365	CbGpPWpGaD
Memantine—GRIN1—Spinal Cord Injury—IL2—brain cancer	0.000205	0.00359	CbGpPWpGaD
Memantine—GRIN2B—EPH-Ephrin signaling—VEGFA—brain cancer	0.000203	0.00357	CbGpPWpGaD
Memantine—GRIN1—Spinal Cord Injury—CCND1—brain cancer	0.0002	0.0035	CbGpPWpGaD
Memantine—HTR3A—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000199	0.00348	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—PTCH2—brain cancer	0.000197	0.00346	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—TRPC6—brain cancer	0.000195	0.00341	CbGpPWpGaD
Memantine—GRIN1—BDNF signaling pathway—RELA—brain cancer	0.000194	0.0034	CbGpPWpGaD
Memantine—HTR3A—SIDS Susceptibility Pathways—CTNNB1—brain cancer	0.00019	0.00333	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—TRPC6—brain cancer	0.00019	0.00333	CbGpPWpGaD
Memantine—GRIN2B—BDNF signaling pathway—RELA—brain cancer	0.000189	0.00332	CbGpPWpGaD
Memantine—SLC22A2—Transmembrane transport of small molecules—S100A10—brain cancer	0.000186	0.00326	CbGpPWpGaD
Memantine—GRIN1—Alzheimers Disease—TP53—brain cancer	0.000181	0.00318	CbGpPWpGaD
Memantine—GRIN2B—Alzheimers Disease—TP53—brain cancer	0.000177	0.0031	CbGpPWpGaD
Memantine—CYP2A6—Fluoropyrimidine Activity—TP53—brain cancer	0.000174	0.00305	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—OR14C36—brain cancer	0.000173	0.00303	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—OR4C12—brain cancer	0.000173	0.00303	CbGpPWpGaD
Memantine—GRIN1—BDNF signaling pathway—CTNNB1—brain cancer	0.000169	0.00296	CbGpPWpGaD
Memantine—HTR3A—SIDS Susceptibility Pathways—VEGFA—brain cancer	0.000167	0.00293	CbGpPWpGaD
Memantine—GRIN2B—BDNF signaling pathway—CTNNB1—brain cancer	0.000164	0.00288	CbGpPWpGaD
Memantine—GRIN1—Spinal Cord Injury—MYC—brain cancer	0.00016	0.00281	CbGpPWpGaD
Memantine—GRIN1—SIDS Susceptibility Pathways—CTNNB1—brain cancer	0.000158	0.00277	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—OR4C12—brain cancer	0.000157	0.00275	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—OR14C36—brain cancer	0.000157	0.00275	CbGpPWpGaD
Memantine—GRIN1—Spinal Cord Injury—EGFR—brain cancer	0.000157	0.00275	CbGpPWpGaD
Memantine—GRIN1—BDNF signaling pathway—STAT3—brain cancer	0.000147	0.00258	CbGpPWpGaD
Memantine—GRIN2B—BDNF signaling pathway—STAT3—brain cancer	0.000143	0.00251	CbGpPWpGaD
Memantine—GRIN1—SIDS Susceptibility Pathways—VEGFA—brain cancer	0.000139	0.00244	CbGpPWpGaD
Memantine—GRIN1—Spinal Cord Injury—TP53—brain cancer	0.000131	0.00231	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—HES1—brain cancer	0.000125	0.0022	CbGpPWpGaD
Memantine—DRD2—Circadian rythm related genes—SIRT1—brain cancer	0.000122	0.00215	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—HES1—brain cancer	0.000122	0.00214	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—SHH—brain cancer	0.000102	0.00178	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—PTCH2—brain cancer	0.000101	0.00177	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—ERBB2—brain cancer	0.000101	0.00177	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—CDK4—brain cancer	9.83e-05	0.00173	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—ERBB2—brain cancer	9.82e-05	0.00172	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—PTCH1—brain cancer	9.62e-05	0.00169	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—SMO—brain cancer	9.62e-05	0.00169	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—CDK4—brain cancer	9.58e-05	0.00168	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—OR14C36—brain cancer	9.27e-05	0.00163	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—OR4C12—brain cancer	9.27e-05	0.00163	CbGpPWpGaD
Memantine—DRD2—Circadian rythm related genes—CDK4—brain cancer	9.26e-05	0.00163	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	9.07e-05	0.00159	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—ABR—brain cancer	8.74e-05	0.00153	CbGpPWpGaD
Memantine—SLC22A2—Transmembrane transport of small molecules—TRPC6—brain cancer	8.59e-05	0.00151	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—ABR—brain cancer	7.94e-05	0.00139	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—DTX2—brain cancer	7.88e-05	0.00138	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—VEGFA—brain cancer	7.76e-05	0.00136	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—VEGFA—brain cancer	7.56e-05	0.00133	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—RELA—brain cancer	7.23e-05	0.00127	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—CYP2C9—brain cancer	7.22e-05	0.00127	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—ERBB2—brain cancer	7.18e-05	0.00126	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—RELA—brain cancer	7.05e-05	0.00124	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—ERBB2—brain cancer	7e-05	0.00123	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—EGFR—brain cancer	6.98e-05	0.00122	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—EGFR—brain cancer	6.8e-05	0.00119	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	6.63e-05	0.00116	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—CYP2C9—brain cancer	6.62e-05	0.00116	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—CTNNB1—brain cancer	6.29e-05	0.0011	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—BSG—brain cancer	6.14e-05	0.00108	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—CTNNB1—brain cancer	6.13e-05	0.00108	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PTCH2—brain cancer	5.97e-05	0.00105	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—HES5—brain cancer	5.79e-05	0.00102	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—BSG—brain cancer	5.63e-05	0.000988	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—STRADA—brain cancer	5.62e-05	0.000986	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—VEGFA—brain cancer	5.53e-05	0.000971	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—TRPC6—brain cancer	5.53e-05	0.000971	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—STAT3—brain cancer	5.48e-05	0.000962	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—VEGFA—brain cancer	5.39e-05	0.000947	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—CYP2C9—brain cancer	5.35e-05	0.000938	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—STAT3—brain cancer	5.34e-05	0.000937	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—IDH1—brain cancer	5.28e-05	0.000926	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—SHH—brain cancer	5.21e-05	0.000914	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—TRPC6—brain cancer	5.02e-05	0.000882	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—EGFR—brain cancer	4.98e-05	0.000874	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—PTCH1—brain cancer	4.94e-05	0.000867	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—SMO—brain cancer	4.94e-05	0.000867	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—EGFR—brain cancer	4.85e-05	0.000852	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—IDH1—brain cancer	4.84e-05	0.00085	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—ABR—brain cancer	4.69e-05	0.000823	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—BSG—brain cancer	4.54e-05	0.000798	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—GLI2—brain cancer	4.53e-05	0.000795	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—GLI1—brain cancer	4.26e-05	0.000747	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—ENO2—brain cancer	4.17e-05	0.000732	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—VAV1—brain cancer	4.15e-05	0.000727	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CYP2C9—brain cancer	4.04e-05	0.000709	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—SUFU—brain cancer	4.04e-05	0.000708	CbGpPWpGaD
Memantine—DRD2—Circadian rythm related genes—TP53—brain cancer	3.94e-05	0.000691	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—IDH1—brain cancer	3.91e-05	0.000686	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—GFAP—brain cancer	3.89e-05	0.000683	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—ENO2—brain cancer	3.83e-05	0.000672	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—VAV1—brain cancer	3.76e-05	0.000661	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—HEY1—brain cancer	3.69e-05	0.000648	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—DLL1—brain cancer	3.62e-05	0.000635	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—BSG—brain cancer	3.43e-05	0.000603	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—ENO2—brain cancer	3.09e-05	0.000542	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—SHH—brain cancer	3.08e-05	0.00054	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—TRPC6—brain cancer	2.97e-05	0.000521	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—IDH1—brain cancer	2.95e-05	0.000518	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PTCH1—brain cancer	2.92e-05	0.000512	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—SMO—brain cancer	2.92e-05	0.000512	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—PIK3CG—brain cancer	2.63e-05	0.000462	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	2.4e-05	0.000422	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—PIK3CG—brain cancer	2.39e-05	0.000419	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—ENO2—brain cancer	2.33e-05	0.00041	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—NOTCH2—brain cancer	2.33e-05	0.000409	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—VAV1—brain cancer	2.22e-05	0.00039	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PIK3CG—brain cancer	1.91e-05	0.000336	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—HES1—brain cancer	1.91e-05	0.000336	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—IL2—brain cancer	1.85e-05	0.000325	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PDGFRA—brain cancer	1.82e-05	0.00032	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—SPP1—brain cancer	1.77e-05	0.00031	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PIK3CG—brain cancer	1.76e-05	0.000308	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—IL2—brain cancer	1.68e-05	0.000295	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—IRS2—brain cancer	1.6e-05	0.000281	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PIK3CG—brain cancer	1.42e-05	0.000249	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—APC—brain cancer	1.41e-05	0.000248	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PIK3CG—brain cancer	1.41e-05	0.000248	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—EGFR—brain cancer	1.29e-05	0.000226	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—RELA—brain cancer	1.1e-05	0.000194	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—ERBB2—brain cancer	1.1e-05	0.000192	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PIK3CG—brain cancer	1.07e-05	0.000188	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—IL2—brain cancer	9.94e-06	0.000174	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CCND1—brain cancer	9.69e-06	0.00017	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CTNNB1—brain cancer	9.59e-06	0.000168	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—VEGFA—brain cancer	8.44e-06	0.000148	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—STAT3—brain cancer	8.36e-06	0.000147	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—MYC—brain cancer	7.77e-06	0.000136	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—EGFR—brain cancer	7.6e-06	0.000133	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—TP53—brain cancer	6.38e-06	0.000112	CbGpPWpGaD
